Ruconest: drug evaluation
Recombinant human C1-inhibitor (Ruconest®) has been granted market authorisation in Europe for the treatment of acute...
Information on this website is exclusively for health care professionals and not the general public.
Are you a qualified Secondary-Care Pharmacist or healthcare professional?


